covaxin - Robuta Search

https://health.economictimes.indiatimes.com/news/pharma/production-to-supply-takes-4-months-says-covaxin-manufacturer/83050246 Production to supply takes 4 months, says Covaxin manufacturer, ETHealthworld Manufacturing to supply of Covid-19 vaccine Covaxin involves four months of lag time depending on technology and regulatory approvals, Bharat Biotech said on... production supply takes months says https://travel.economictimes.indiatimes.com/news/destination/global/who-says-likely-to-receive-clarifications-from-bharat-biotech-on-covaxin-by-weekend/87327186 WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend, ETTravelWorld The World Health Organisation's Technical Advisory Group met on October 26 and "decided that additional clarifications from the manufacturer (Bharat Biotech)... https://www.livemint.com/news/india/covaxin-india-extends-shelf-life-of-bharat-biotech-s-covid-vaccine-to-12-months-11635933943649.html?ref=drishtikone.com Covaxin: India extends shelf life of Bharat Biotech's Covid vaccine to 12 months | Today News Nov 3, 2021 - Currently, the shelf life of the vaccine is 6 months from the date of manufacture https://health.economictimes.indiatimes.com/news/industry/media-reports-claiming-covaxin-has-who-eul-for-15-18-age-group-are-misleading-centre/88751697 Media reports claiming Covaxin has WHO EUL for 15-18 age group are Misleading: Centre, ETHealthworld https://health.economictimes.indiatimes.com/news/pharma/covid-19-phase-3-trial-of-covaxin-to-begin-in-ups-lucknow-gorakhpur-from-october/78311504 Covid-19: Phase-3 trial of COVAXIN to begin in UP's Lucknow, Gorakhpur from October, ETHealthworld Corona Vaccine: The Indian Council for Medical Research (ICMR) is collaborating with Bharat Biotech for the development of the COVAXIN. https://health.economictimes.indiatimes.com/news/industry/covaxin-pediatric-trials-to-begin-this-week-experts-hail-move/83139344 Covid Third Wave: Covaxin pediatric trials to begin this week, experts hail move, ETHealthworld Covid Third Wave: The five institutions where the trials will be conducted are All India Institute of Medical Sciences (AIIMS) in Patna, Prakhar Hospital in... https://health.economictimes.indiatimes.com/news/pharma/bharat-biotech-has-submitted-covaxins-phase-iii-trial-data-to-dcgi-govt-sources/83734973 Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt sources, ETHealthworld Drugs Controller General Of India: Bharat Biotech's Covaxin is one of the three vaccines which are currently being used in India. The phase III data of its... https://health.economictimes.indiatimes.com/tag/covaxin+or+covishield Covaxin or covishield - Latest covaxin or covishield , Information & Updates - Health -ET... ETHealthworld.com brings latest covaxin or covishield news, views and updates from all top sources for the Indian Health industry. latest information covaxin covishield updates health https://swachhindia.ndtv.com/bharat-biotech-starts-phase-iii-trials-for-covid-19-vaccine-covaxin-53007/ Bharat Biotech Starts Phase III Trials For COVID-19 Vaccine COVAXIN | News Nov 17, 2020 - COVAXIN has been evaluated in about 1,000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity data bharat biotech phase iii https://health.economictimes.indiatimes.com/news/hospitals/aiims-delhi-to-start-screening-children-for-covaxin-trials-from-monday/83297124 Bharat Biotech: AIIMS Delhi to start screening children for Covaxin trials from Monday,... Bharat Biotech: AIIMS Delhi will be starting clinical trials after AIIMS Patna which started the trials recently on children aged between 12 and 18 years old. https://indianexpress.com/article/india/india-new-covid-deaths-cases-third-wave-vaccine-7443962/ Better immune response from mixing Covaxin, Covishield, says ICMR study | India News - The Indian... Aug 9, 2021 - While Covishield is built on a viral vector vaccine platform and uses a weakened version of adenovirus, a common cold virus that causes infection in... https://health.economictimes.indiatimes.com/news/pharma/allowing-corbevax-as-booster-for-those-vaccinated-with-coivishield-covaxin-likely-to-be-considered-by-ntagi/92500545 Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered... Ntagi: The Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precaution dose for those aged 18 and above. India's first... https://legal.economictimes.indiatimes.com/news/industry/grievances-on-shortage-of-covaxin-for-second-dose-in-18-44-yrs-age-group-in-delhi-addressed-hc/83459406 Grievances on shortage of Covaxin for second dose in 18-44 yrs age group in Delhi addressed: HC,... Delhi High Court: The court was informed that the Delhi Chief Secretary has issued an order on June 6 that the Delhi Disaster Management Authority (DDMA) has... https://health.economictimes.indiatimes.com/news/pharma/uk-to-add-covaxin-to-approved-list-from-november-22/87603721 Uk Approves Covaxin: UK to add Covaxin to approved list from November 22, ETHealthworld Uk Approves Covaxin: The move follows the World Health Organisation's (WHO) Emergency Use Listing for Covaxin, which is the second most used formulation in... to add approved list uk approves covaxin https://legal.economictimes.indiatimes.com/news/industry/fda-rejects-eua-for-covaxin-suggests-biologics-licence-application-route-for-approval-in-us/83428971 FDA rejects EUA for Covaxin, 'suggests' Biologics Licence Application route for approval in US,... Ocugen in a statement on Thursday announced that as recommended by theFDA,it will pursue submission of a biologics licence application (BLA) for Covaxin. https://health.economictimes.indiatimes.com/news/industry/who-to-give-approval-to-covaxin-this-month-say-top-health-experts/86723076 WHO to give approval to Covaxin this month, say top health experts, ETHealthworld WHO's Strategic Advisory Group of Expert on Immunization (SAGE) will be conducting a meeting on October 5 regarding EUL to Covaxin. to give this month https://health.economictimes.indiatimes.com/news/industry/haryana-hoping-to-get-1000-volunteers-for-covaxin-trial-says-pgims-v-c/79303895 Haryana: Hoping to get 1000 volunteers for Covaxin trial, says PGIMS V-C, ETHealthworld https://economictimes.indiatimes.com/industry/healthcare-ngo-raises-concerns-over-covaxin/articleshow/80296139.cms Healthcare NGO raises concerns over Covaxin - The Economic Times A day before India begins the worlds largest Covid-19 vaccination drive, a group of healthcare-focused NGOs has sought clarifications from the government on... healthcare ngo raises concerns covaxin https://health.economictimes.indiatimes.com/news/pharma/hester-in-talks-with-bharat-biotech-for-production-of-covid-19-vaccine-via-technology-transfer/82680117 Covaxin: Hester in talks with Bharat Biotech for production of Covid-19 vaccine via technology... Covaxin: A triparty consortium has been formed with the Government of Gujarat as the lead partner, to explore the prospects of manufacturing the Covid vaccine... https://www.thenationalnews.com/uae/health/coronavirus-india-s-covaxin-found-to-be-81-effective-against-covid-19-in-phase-3-trials-1.1177417 Coronavirus: India's Covaxin found to be 81% effective against Covid-19 in phase 3 trials | The... Jul 2, 2021 - Participants were aged between 18- to 98-years-old, including 2,433 over the age of 60 and 4,500 with comorbidities https://travel.economictimes.indiatimes.com/news/ministry/whos-approval-to-covaxin-to-significantly-ease-travel-for-vaccinated-indians-mea/87659079 WHO's approval to Covaxin to significantly ease travel for vaccinated Indians: MEA, ETTravelWorld 96 countries have either accepted WHO-approved vaccines, which would include both Covishield and Covaxin, or in some cases only Covishield or Covaxin. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/study-on-covaxin-reports-adverse-events-in-some-participants-who-took-the-covid-19-vaccine/videoshow/110164564.cms Study on Covaxin reports adverse events in some participants who took the Covid-19 vaccine - The... Nearly a third of the participants of an observational study on the side-effects of Bharat Biotech's Covid-19 vaccine Covaxin reported adverse events of... https://travel.economictimes.indiatimes.com/news/destination/global/covaxin-a-list-of-countries-that-have-approved-the-vaccine-so-far/87481847 Covaxin: A list of countries that have approved the vaccine so far, ETTravelWorld The World Health Organisation's technical advisory group is scheduled to meet on November 3 for a final risk-benefit assessment for the Emergency Use Listing... list of countries https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/expert-panel-recommends-bharat-biotech-s-covaxin-for-emergency-use-dcgi-to-take-final-call-1755318-2021-01-02 Bharat BioTech's Covaxin gets expert panel's recommendation for emergency use, DCGI to take final... Jan 3, 2021 - A govt-appointed expert panel has recommended that Bharat BioTech's Covid-19 vaccine, Covaxin, should be given restricted emergency use in India. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/bhu-study-on-covaxin-had-serious-methodological-flaws-as-per-icmr-prataprao-jadhav/articleshow/112317277.cms BHU study on Covaxin had serious methodological flaws as per ICMR: Prataprao Jadhav - The Economic... The Indian Council of Medical Research (ICMR) reviewed a study on the long-term safety of Covaxin in adults and adolescents, conducted by Banaras Hindu... https://health.economictimes.indiatimes.com/news/pharma/bharat-biotech-seeks-dcgi-nod-for-phase-2/3-covaxin-booster-trial-among-two-to-18-year-old/91314598 Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old,... Bharat Biotech: The study is likely to be conducted at six sites, including AIIMS Delhi and Patna. India began administering precaution doses of vaccines to... https://health.economictimes.indiatimes.com/news/pharma/tga-australia-recognizes-covaxin-and-bbibp-corv/87462047 TGA Australia recognizes Covaxin and BBIBP-CorV, ETHealthworld Australia's medicines and medical devices regulator has recognized India's Bharat Biotech's Covaxin vaccine as a valid vaccine to establish the vaccination... tga australia recognizes covaxin https://www.business-standard.com/article/current-affairs/gujarat-over-750-volunteers-get-covaxin-first-dose-in-phase-3-trial-120122700401_1.html Gujarat: Over 750 volunteers get Covaxin first dose in phase-3 trial | Coronavirus Latest News -... None of them have experienced any side effects so far, a senior doctor said on Sunday https://health.economictimes.indiatimes.com/news/pharma/ocugen-pays-usd-15-mn-upfront-to-bharat-biotech-for-covaxin-rights-in-canada/83331708 Covid-19 Vaccine: Ocugen pays USD 15 mn upfront to Bharat Biotech for Covaxin rights in Canada,... Covid-19 Vaccine: Bharat Biotech on June 3 said it has agreed to expand the agreement with Ocugen Inc to commercialise the jab in Canada also. https://health.economictimes.indiatimes.com/news/industry/govt-rubbishes-reports-on-approval-for-covaxin-due-to-political-pressure/95590471 Govt rubbishes reports on approval for Covaxin due to political pressure, ETHealthworld The Union Health Ministry on Thursday termed as "misleading" and "fallacious" media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin... on approval https://health.economictimes.indiatimes.com/news/pharma/phase-3-trial-of-bharat-biotechs-covaxin-commences-in-aiims/79428680 Phase-3 trial of Bharat Biotech's Covaxin commences in AIIMS, ETHealthworld Covaxin: Dr Srivastava was the first one to receive the shot, which would be given to around 15,000 volunteers at the AIIMS over the next few days, sources... bharat biotech https://health.economictimes.indiatimes.com/news/pharma/bharat-biotech-ocugen-committed-to-bring-covid-19-vaccine-covaxin-in-us-canada/90060876 Pediatric Use Of Covaxin: Bharat Biotech, Ocugen committed to bring COVID-19 vaccine Covaxin in US,... Pediatric Use Of Covaxin: Bharat Biotech on Monday said it, along with its partner Ocugen, is fully committed to bringing COVID-19 vaccine Covaxin in the US... https://legal.economictimes.indiatimes.com/tag/covaxin+clinical+trial Covaxin clinical trial - Latest covaxin clinical trial , Information & Updates - Legal -ET... ETLegalWorld.com brings latest covaxin clinical trial news, views and updates from all top sources for the Indian Legal industry. clinical trial latest information covaxin updates legal https://government.economictimes.indiatimes.com/news/healthcare/dcgi-approves-phase-ii/iii-clinical-trial-of-covaxin-in-2-18-years-age-group/82625506 DCGI approves phase II/III clinical trial of COVAXIN in 2-18 years age group, ETGovernment Hyderabad-based Bharat Biotech to conduct trials in 525 healthy volunteers https://travel.economictimes.indiatimes.com/news/destination/global/germany-to-recognise-bharat-biotechs-covaxin-for-travel-from-june-1/91816263 Covaxin Vaccine: Germany to recognise Bharat Biotech's Covaxin for travel from June 1, ETTravelWorld Covaxin Vaccine: In a tweet, German Ambassador to India and Bhutan, Walter J Lindner welcomed the decision of recognition of the WHO-listed Covaxin for travels... https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/documents-for-covaxin-emergency-use-listing-submitted-to-who-expect-approval-at-earliest-bharat-biotech/articleshow/84354785.cms All documents for Covaxin emergency use listing submitted to WHO, expect approval at earliest:... According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies. https://travel.economictimes.indiatimes.com/news/destination/global/canada-to-accept-travellers-vaccinated-with-covaxin-from-nov-30/87813794 Canada Entry: Canada to accept travellers vaccinated with Covaxin from Nov 30, ETTravelWorld Canada Entry: Along with Covaxin, travellers fully vaccinated with Sinopharm and Sinovac will also be allowed to enter the country. In a change of border... https://health.economictimes.indiatimes.com/news/pharma/bharat-biotech-to-ramp-up-covaxin-production-by-additional-200-million-doses/82820611 Covid-19 Vaccine: Bharat Biotech to ramp up Covaxin production by additional 200 million doses,... Covid-19 Vaccine: The Hyderabad-based firm said it will utilise the Ankleshwar-based production facility of its wholly-owned subsidiary Chiron Behring Vaccines... https://health.economictimes.indiatimes.com/news/pharma/covaxin-approved-for-emergency-use-in-13-countries-mos-for-health-bharati-pravin-pawar/89441535 COVAXIN approved for emergency use in 13 countries: MoS for Health Bharati Pravin Pawar,... Covaxin has been granted approval for emergency use in 13 countries as of January 31, 2022, according to the WHO, said Minister of State (MoS) for Health... https://travel.economictimes.indiatimes.com/news/destination/global/we-trust-bharat-biotech-has-been-submitting-data-regularly-very-quickly-who-official-on-covaxin-eul/87344937 We trust Bharat Biotech has been submitting data regularly, very quickly: WHO official on Covaxin... The technical advisory group will reconvene on November 2 for the final risk-benefit assessment of Covaxin EUL. https://health.economictimes.indiatimes.com/news/diagnostics/over-21k-tested-positive-for-covid-19-after-taking-first-dose-of-either-covishield-or-covaxin-govt/82185112 Over 21k tested positive for Covid-19 after taking first dose of either Covishield or Covaxin:... ICMR Director General Balram Bhargava said 0.04 per cent of 17,37,178 individuals, who received the second dose of Covaxin, were positive for Covid-19, while... https://health.economictimes.indiatimes.com/news/pharma/covishield-immune-responses-against-covid-variants-higher-than-covaxin-study/96813119 Covishield immune responses against COVID variants higher than Covaxin: Study, ETHealthworld Covishield elicited immune responses of higher magnitude and breadth than Covaxin in both seronegative individuals and seropositive individuals, across cohorts... immune responses covid variants covishield https://health.economictimes.indiatimes.com/news/diagnostics/bharat-biotechs-covaxin-shows-encouraging-results-in-clinical-trials-research-paper/79933180 Bharat Biotech's Covaxin shows encouraging results in clinical trials: Research paper, ETHealthworld Covid Vaccine: In a double-blind, randomised, multi-centre phase 2 clinical trials, a total of 380 healthy children and adults were randomised and administered... https://health.economictimes.indiatimes.com/news/industry/more-information-required-from-bharat-biotech-for-emergency-use-listing-of-covaxin-who/82928103 More information required from Bharat Biotech for emergency use listing of Covaxin: WHO,... Covid-19 Vaccines: According to the WHO, submissions to it for prequalification or listing under the emergency use procedure are confidential. https://www.straitstimes.com/asia/south-asia/indias-covaxin-778-effective-against-covid-19-in-lancet-study India's Covaxin 77.8% effective against Covid-19 in Lancet study | The Straits Times Nov 12, 2021 - No severe adverse events were recorded during a randomised trial involving 24,419 participants. Read more at straitstimes.com. https://health.economictimes.indiatimes.com/news/pharma/bharat-biotech-asked-to-provide-more-data-on-covid-19-vaccine-covaxin-for-children-aged-below-12/90999033 Bharat Biotech asked to provide more data on Covid-19 vaccine Covaxin for children aged below 12,... The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its Covid-19 vaccine,... https://www.ndtv.com/india-news/coronavirus-vaccine-who-shouldnt-take-covaxin-shot-bharat-biotechs-fact-sheet-2354544 Coronavirus Vaccine: Who Shouldn't Take Covaxin Shot? Bharat Biotech's Fact-Sheet Those who have weaker immunity or are on a medicine that affects their immune system and people with allergies must not take the Covaxin shot, vaccine-makers... https://www.india.com/news/india/covishield-and-covaxin-to-get-regular-market-approval-from-dcgi-soon-each-dose-likely-to-be-capped-at-rs-275-5207198/ Covishield and Covaxin To Get Regular Market Approval From DCGI Soon, Each Dose Likely To be Capped... Jan 26, 2022 - The National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines affordable. https://www.indiatoday.in/india/video/covaxin-77-8-effective-against-covid-phase-3-data-lancet-1876242-2021-11-13 Covaxin 77.8% effective against Covid phase 3 data Lancet - Covaxin 77.8% effective against Covid:... Nov 13, 2021 - After the World Health Organisation (WHO) approved Bharat Biotech's Covaxin for emergency use, medical journal Lancet has now stated that the made-in-India... covaxin effective covid phase data https://travel.economictimes.indiatimes.com/news/travel-agents/outbound/with-pm-modi-vaccinated-with-covaxin-indian-travel-trade-relaxed-over-international-approvals/82907108 With PM Modi vaccinated with Covaxin, Indian travel trade relaxed over international approvals,... Covaxin is among 19 vaccine candidates from different parts of the world waiting approval from WHO. pm modi https://rajeev2004.blogspot.com/2021/04/icmr-study-covaxin-neutralises-double.html Shadow Warrior: ICMR Study: Covaxin Neutralises Double Mutant | Coronavirus Vaccine A Hindu Nationalist Perspective shadow warrior icmr study covaxin double https://health.economictimes.indiatimes.com/news/pharma/no-impact-on-efficacy-and-safety-of-covaxin-bharat-biotech-after-who-suspension/90622334 No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension, ETHealthworld "For the millions who have received COVAXIN, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety of the vaccine,"... https://government.economictimes.indiatimes.com/news/healthcare/govt-places-orders-for-44-crore-doses-of-covishield-covaxin/83370223 Govt places orders for 44 crore doses of Covishield & Covaxin, ETGovernment These 44 crore doses of Covid-19 vaccines will be delivered by their makers between August and December 2021, the Union Health Ministry said. govt places orders https://www.indiatoday.in/coronavirus-outbreak/story/covaxin-second-dose-beneficiaries-18-44-age-group-delhi-govt-1811637-2021-06-06 Covaxin to be given only to second dose beneficiaries in 18-44 age group: Delhi govt - India Today Jun 7, 2021 - The Delhi government began vaccinating those in the 18-44 years age group on May 1. Three weeks later, the inoculation drive was suspended due to an acute... https://health.economictimes.indiatimes.com/news/pharma/assam-writes-to-centre-advance-covaxin-trials-in-state-hospital/78484442 Assam writes to Centre: Advance Covaxin trials in state hospital, ETHealthworld Covid Vaccine: In a move that potentially opens up a whole new vaccine debate, Assam has officially written to the Centre with a skip-the-line request for... in state assam writes centre advance https://www.business-standard.com/article/current-affairs/govt-caps-maximum-price-of-covishield-covaxin-sputnik-v-for-pvt-hospitals-121060801560_1.html Govt caps maximum price of Covishield, Covaxin, Sputnik V for pvt hospitals | Coronavirus Latest... The govt has set the maximum price private hospitals can charge for the three Covid vaccines currently available in the country -- Covishield Rs 780 per dose,... https://health.economictimes.indiatimes.com/news/pharma/bharat-biotechs-us-partner-ocugen-submits-master-file-to-fda-on-covaxin/82932617 Covid-19 Vaccine: Bharat Biotech's US partner Ocugen submits "Master File" to FDA on Covaxin,... Covid-19 Vaccine: The company is currently evaluating the clinical and regulatory path for Covaxin in the United States including obtaining Emergency Use... https://health.economictimes.indiatimes.com/news/hospitals/resident-doctors-in-rml-hospital-want-covishield-expresses-bit-apprehension-about-covaxin/80301499 Resident doctors in RML Hospital want Covishield, expresses 'bit apprehension' about Covaxin,... "The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose... resident doctors https://travel.economictimes.indiatimes.com/news/destination/global/sri-lanka-reopens-for-fully-vaccinated-indian-travellers-including-those-jabbed-with-covaxin/85623775 Sri Lanka reopens for fully-vaccinated Indian travellers including those jabbed with Covaxin,... Anyone travelling from India, who has completed both the doses of either Covishield or Covaxin will be allowed entry into the island nation.